Larry Weiss is an accomplished inventor based in San Francisco, CA. He holds a total of 8 patents that reflect his significant contributions to the field of biotechnology. His work primarily focuses on the development of innovative solutions for health-related issues.

Latest Patents

One of his latest patents is for an optimized strain of ammonia-oxidizing bacteria designated as D23, D23-100, or AOB D23-100. This strain exhibits desirable properties, such as the ability to suppress the growth of pathogenic bacteria and an enhanced capacity to produce nitric oxide and its precursors. This innovation may be utilized to treat diseases associated with low nitrite levels, skin diseases, and infections caused by pathogenic bacteria. Another notable patent involves a method for treating skin disorders, such as acne vulgaris, through the topical administration of ammonia-oxidizing bacteria. This method provides a novel approach to managing skin conditions effectively.

Career Highlights

Throughout his career, Larry Weiss has worked with various companies, including Aobiome LLC and Ohsoclean, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking advancements in biotechnology.

Collaborations

Larry has collaborated with notable individuals in his field, including David R. Whitlock and Spiros Jamas. These partnerships have further enhanced his innovative capabilities and expanded the impact of his work.

Conclusion

Larry Weiss is a prominent inventor whose work in biotechnology has led to significant advancements in health treatments. His patents demonstrate a commitment to addressing critical health issues through innovative solutions.

This text is generated by artificial intelligence and may not be accurate.